Last updated on October 2018

Study to Compare Oral PF-06651600 PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis


Brief description of study

The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Clinical Study Identifier: NCT02958865

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Clinical Centre of Kragujevac
Kragujevac, Serbia
  Connect »